Evonik
Mathias Appelt has a strong background in the chemical industry, with experience in various roles related to technology and research and development. Mathias began their career in 2003 as a Project Manager at Rhodia Specialty Silicones, where they focused on silicone formulations. In 2007, they moved to Bluestar Silicones as a Lab Manager, specializing in R&D for silicones. In 2008, they became the Head of Applied Technology at hanse chemie AG, leading the company's application technology department. Since 2012, Mathias has been working at Evonik as the Head of Applied Technology, utilizing their expertise in this field.
Mathias Appelt has a doctorate degree (Dr. rer. nat.) in Chemistry from Technische Universität Clausthal, which they obtained from 2000 to 2003. Mathias also holds a Diplomchemiker degree in Chemistry from the same university, which they completed from 1992 to 1999. Furthermore, they briefly studied Organic Synthetic Chemistry at the University of Aberdeen in 1996. In addition, they attended Eindhoven University of Technology in the year 2000, but no degree or field of study is specified.
This person is not in the org chart
This person is not in any teams
Evonik
12 followers
Evonik is a Germany-based specialty chemicals company that operates in four segments: The Nutrition and Care segment produces specialty chemicals, mainly for use in consumer goods for daily needs and food, as well as nutrition for animal food and healthcare products; the Resource Efficiency segment offers material solutions for environment-friendly and energy-efficient products used in the automotive, adhesives and construction industries, among others; the Performance Materials segment produces polymer materials and their intermediates, mainly for the rubber, plastics and agriculture sectors, and the Services segment comprises site management, utilities and waste management, as well as technical, process technology, engineering and logistics services for the chemicals segments and external customers at the Company's sites. Its majority shareholder is RAG Stiftung.